$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Option Exercise | A | 103.57 | 6,176 | 639,648 | 6,176 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 0.00 | 541 | 0 | 5,180 | 4.6 K to 5.2 K (+11.66 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | A | 103.57 | 48,555 | 5,028,841 | 48,555 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 0.00 | 4,249 | 0 | 42,345 | 38.1 K to 42.3 K (+11.15 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | A | 103.57 | 33,103 | 3,428,478 | 33,103 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 0.00 | 2,897 | 0 | 42,472 | 39.6 K to 42.5 K (+7.32 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Option Exercise | A | 103.57 | 27,589 | 2,857,393 | 27,589 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Grant | A | 0.00 | 2,414 | 0 | 73,097 | 70.7 K to 73.1 K (+3.42 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | A | 103.57 | 171,061 | 17,716,788 | 171,061 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Grant | A | 0.00 | 14,966 | 0 | 181,082 | 166.1 K to 181.1 K (+9.01 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 103.57 | 28,690 | 2,971,423 | 28,690 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 2,511 | 0 | 42,888 | 40.4 K to 42.9 K (+6.22 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 103.57 | 33,103 | 3,428,478 | 33,103 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 2,897 | 0 | 72,312 | 69.4 K to 72.3 K (+4.17 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Option Exercise | A | 103.57 | 38,623 | 4,000,184 | 38,623 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 0.00 | 3,380 | 0 | 21,661 | 18.3 K to 21.7 K (+18.49 %) |
Jan 31 2018 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | M | 58.18 | 106,840 | 6,215,417 | 0 | |
Jan 31 2018 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Sell | S | 107.00 | 106,840 | 11,431,880 | 166,116 | 273 K to 166.1 K (-39.14 %) |
Jan 31 2018 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Buy | M | 58.18 | 106,840 | 6,215,417 | 272,956 | 166.1 K to 273 K (+64.32 %) |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 52.17 | 21,294 | 1,110,802 | 0 | |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.00 | 21,294 | 2,214,576 | 69,415 | 90.7 K to 69.4 K (-23.48 %) |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 52.17 | 21,294 | 1,110,802 | 90,709 | 69.4 K to 90.7 K (+30.68 %) |
Jan 04 2018 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 312 | 0 | 6,206 | |
Jan 04 2018 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 52.17 | 63,880 | 3,332,300 | 0 | |
Jan 04 2018 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 98.68 | 63,880 | 6,303,359 | 38,053 | 101.9 K to 38.1 K (-62.67 %) |
Jan 04 2018 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 52.17 | 63,880 | 3,332,300 | 101,423 | 37.5 K to 101.4 K (+170.15 %) |
Jan 04 2018 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 99.12 | 2,256 | 223,615 | 18,281 | 20.5 K to 18.3 K (-10.99 %) |
Oct 17 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 91.10 | 9 | 820 | 4,515 | 4.5 K to 4.5 K (-0.20 %) |
Oct 04 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 330 | 0 | 5,867 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 61.23 | 5,221 | 319,656 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 61.23 | 5,592 | 342,370 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 57.57 | 4,268 | 245,687 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 57.57 | 5,592 | 321,903 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 57.67 | 5,592 | 322,463 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 55.76 | 7,319 | 408,107 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 51.55 | 7,316 | 377,140 | 0 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 108.07 | 40,900 | 4,419,940 | 34,675 | 75.6 K to 34.7 K (-54.12 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 61.23 | 5,592 | 342,370 | 75,575 | 70 K to 75.6 K (+7.99 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 57.57 | 5,592 | 321,903 | 69,983 | 64.4 K to 70 K (+8.68 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 61.23 | 5,221 | 319,656 | 64,391 | 59.2 K to 64.4 K (+8.82 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 57.57 | 4,268 | 245,687 | 59,170 | 54.9 K to 59.2 K (+7.77 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 57.67 | 5,592 | 322,463 | 54,902 | 49.3 K to 54.9 K (+11.34 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 55.76 | 7,319 | 408,107 | 49,310 | 42 K to 49.3 K (+17.43 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 51.55 | 7,316 | 377,140 | 41,991 | 34.7 K to 42 K (+21.10 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | M | 58.18 | 5,302 | 308,444 | 106,840 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | M | 58.18 | 53,933 | 3,137,552 | 112,142 | |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Sell | S | 108.12 | 5,302 | 573,236 | 166,116 | 171.4 K to 166.1 K (-3.09 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Buy | M | 58.18 | 5,302 | 308,444 | 171,418 | 166.1 K to 171.4 K (+3.19 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Sell | S | 108.16 | 53,933 | 5,833,609 | 166,116 | 220 K to 166.1 K (-24.51 %) |
Sep 13 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Buy | M | 58.18 | 53,933 | 3,137,552 | 220,049 | 166.1 K to 220 K (+32.47 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 61.23 | 1,004 | 61,470 | 5,221 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 57.57 | 915 | 52,672 | 4,268 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 57.67 | 519 | 29,928 | 5,592 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 55.76 | 681 | 37,973 | 7,319 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 51.55 | 684 | 35,260 | 7,316 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 108.01 | 3,803 | 410,762 | 34,675 | 38.5 K to 34.7 K (-9.88 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 61.23 | 1,004 | 61,470 | 38,478 | 37.5 K to 38.5 K (+2.68 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 57.57 | 915 | 52,672 | 37,474 | 36.6 K to 37.5 K (+2.50 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 57.67 | 519 | 29,931 | 36,559 | 36 K to 36.6 K (+1.44 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 55.76 | 681 | 37,973 | 36,040 | 35.4 K to 36 K (+1.93 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 51.55 | 684 | 35,260 | 35,359 | 34.7 K to 35.4 K (+1.97 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | M | 58.18 | 2,525 | 146,892 | 166,075 | |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Sell | S | 108.03 | 2,525 | 272,768 | 166,116 | 168.6 K to 166.1 K (-1.50 %) |
Sep 07 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Buy | M | 58.18 | 2,525 | 146,892 | 168,413 | 165.9 K to 168.4 K (+1.52 %) |
Aug 08 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 106.66 | 296 | 31,571 | 6,000 | 6.3 K to 6 K (-4.70 %) |
Aug 03 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Gift | G | 0.00 | 2,500 | 0 | 70,683 | 73.2 K to 70.7 K (-3.42 %) |
Jul 31 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 108.73 | 1,304 | 141,783 | 6,296 | 7.6 K to 6.3 K (-17.16 %) |
Jul 05 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 276 | 0 | 5,516 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Option Exercise | M | 52.17 | 63,880 | 3,332,300 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Option Exercise | M | 56.12 | 29,340 | 1,646,561 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Option Exercise | M | 57.61 | 13,680 | 788,036 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 108.13 | 2,559 | 276,715 | 73,183 | 75.7 K to 73.2 K (-3.38 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 107.53 | 61,321 | 6,593,786 | 75,742 | 137.1 K to 75.7 K (-44.74 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 108.14 | 1,158 | 125,223 | 137,063 | 138.2 K to 137.1 K (-0.84 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 107.53 | 28,182 | 3,030,326 | 138,221 | 166.4 K to 138.2 K (-16.94 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 108.15 | 336 | 36,338 | 166,403 | 166.7 K to 166.4 K (-0.20 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Sell | S | 107.52 | 13,344 | 1,434,747 | 166,739 | 180.1 K to 166.7 K (-7.41 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Buy | M | 52.17 | 63,880 | 3,332,300 | 180,083 | 116.2 K to 180.1 K (+54.97 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Buy | M | 56.12 | 29,340 | 1,646,561 | 116,203 | 86.9 K to 116.2 K (+33.78 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Buy | M | 57.61 | 13,680 | 788,036 | 86,863 | 73.2 K to 86.9 K (+18.69 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 56.12 | 6,595 | 370,111 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 57.61 | 44,000 | 2,534,620 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 57.35 | 9,167 | 525,727 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.15 | 177 | 19,143 | 69,415 | 69.6 K to 69.4 K (-0.25 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.54 | 6,418 | 690,217 | 69,592 | 76 K to 69.6 K (-8.44 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.14 | 1,364 | 147,504 | 76,010 | 77.4 K to 76 K (-1.76 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.52 | 42,636 | 4,584,223 | 77,374 | 120 K to 77.4 K (-35.53 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.16 | 315 | 34,069 | 120,010 | 120.3 K to 120 K (-0.26 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.54 | 8,852 | 951,962 | 120,325 | 129.2 K to 120.3 K (-6.85 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 56.12 | 6,595 | 370,111 | 129,177 | 122.6 K to 129.2 K (+5.38 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 57.61 | 44,000 | 2,534,620 | 122,582 | 78.6 K to 122.6 K (+55.99 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 57.35 | 9,167 | 525,727 | 78,582 | 69.4 K to 78.6 K (+13.21 %) |
May 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Gift | G | 0.00 | 4,740 | 0 | 69,415 | 74.2 K to 69.4 K (-6.39 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,573 | 0 | 34,675 | 33.1 K to 34.7 K (+4.75 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Grant | A | 0.00 | 1,573 | 0 | 14,585 | 13 K to 14.6 K (+12.09 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 1,573 | 0 | 15,534 | 14 K to 15.5 K (+11.27 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 1,573 | 0 | 14,691 | 13.1 K to 14.7 K (+11.99 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Grant | A | 0.00 | 1,573 | 0 | 7,600 | 6 K to 7.6 K (+26.10 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 1,573 | 0 | 8,525 | 7 K to 8.5 K (+22.63 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Grant | A | 0.00 | 1,573 | 0 | 21,476 | 19.9 K to 21.5 K (+7.90 %) |
May 18 2017 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,573 | 0 | 24,960 | 23.4 K to 25 K (+6.73 %) |
Apr 26 2017 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 57.67 | 6,111 | 352,421 | 0 | |
Apr 26 2017 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 104.03 | 6,111 | 635,727 | 19,903 | 26 K to 19.9 K (-23.49 %) |
Apr 26 2017 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 57.67 | 6,111 | 352,421 | 25,996 | 19.9 K to 26 K (+30.73 %) |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 56.82 | 28,500 | 1,619,370 | 0 | |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 55.65 | 1,013 | 56,373 | 0 | |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 100.00 | 28,500 | 2,850,000 | 40,327 | 68.8 K to 40.3 K (-41.41 %) |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 56.82 | 28,500 | 1,619,370 | 68,822 | 40.3 K to 68.8 K (+70.68 %) |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 100.00 | 1,013 | 101,300 | 40,322 | 41.3 K to 40.3 K (-2.45 %) |
Apr 24 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 55.65 | 1,013 | 56,373 | 41,335 | 40.3 K to 41.3 K (+2.51 %) |
Apr 05 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 315 | 0 | 5,216 | |
Apr 05 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 315 | 0 | 5,216 | |
Mar 20 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 55.65 | 13,987 | 778,377 | 1,013 | |
Mar 20 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 100.00 | 13,987 | 1,398,700 | 40,322 | 54.3 K to 40.3 K (-25.75 %) |
Mar 20 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 55.65 | 13,987 | 778,377 | 54,309 | 40.3 K to 54.3 K (+34.69 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 98.29 | 4,478 | 440,143 | 40,322 | 44.8 K to 40.3 K (-10.00 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 98.29 | 6,028 | 592,492 | 74,155 | 80.2 K to 74.2 K (-7.52 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 98.25 | 1,134 | 111,416 | 80,183 | 81.3 K to 80.2 K (-1.39 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 98.12 | 6,492 | 636,995 | 81,317 | 87.8 K to 81.3 K (-7.39 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 98.12 | 12,520 | 1,228,462 | 87,809 | 75.3 K to 87.8 K (+16.63 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 98.12 | 4,824 | 473,331 | 44,800 | 49.6 K to 44.8 K (-9.72 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 98.12 | 9,302 | 912,712 | 49,619 | 40.3 K to 49.6 K (+23.07 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 97.77 | 470 | 45,952 | 40,317 | 40.8 K to 40.3 K (-1.15 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 98.12 | 419 | 41,112 | 4,330 | 4.7 K to 4.3 K (-8.82 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 98.12 | 1,217 | 119,412 | 4,722 | 3.5 K to 4.7 K (+34.72 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 98.12 | 7,420 | 728,050 | 49,917 | 57.3 K to 49.9 K (-12.94 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 98.12 | 14,309 | 1,403,999 | 57,337 | 43 K to 57.3 K (+33.26 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 98.12 | 7,421 | 728,149 | 37,543 | 45 K to 37.5 K (-16.50 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 98.12 | 12,520 | 1,228,462 | 44,918 | 32.4 K to 44.9 K (+38.64 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 98.12 | 6,492 | 636,995 | 39,052 | 45.5 K to 39.1 K (-14.25 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 98.12 | 12,520 | 1,228,462 | 45,498 | 33 K to 45.5 K (+37.96 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Payment of Exercise | F | 98.12 | 26,891 | 2,638,545 | 165,888 | 192.8 K to 165.9 K (-13.95 %) |
Mar 03 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Grant | A | 98.12 | 47,934 | 4,703,284 | 192,682 | 144.7 K to 192.7 K (+33.12 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 96.42 | 69 | 6,653 | 3,505 | 3.6 K to 3.5 K (-1.93 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 96.42 | 585 | 56,406 | 75,289 | 75.9 K to 75.3 K (-0.77 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Payment of Exercise | F | 96.42 | 3,163 | 304,976 | 144,748 | 147.9 K to 144.7 K (-2.14 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 96.42 | 507 | 48,885 | 40,787 | 41.3 K to 40.8 K (-1.23 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 96.42 | 675 | 65,084 | 32,398 | 33.1 K to 32.4 K (-2.04 %) |
Feb 24 2017 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 95.51 | 2,000 | 191,016 | 16,557 | 18.6 K to 16.6 K (-10.78 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | A | 95.80 | 187,845 | 17,994,612 | 187,845 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Grant | A | 0.00 | 15,659 | 0 | 150,670 | 135 K to 150.7 K (+11.60 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 95.80 | 32,551 | 3,118,223 | 32,551 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 2,715 | 0 | 42,208 | 39.5 K to 42.2 K (+6.87 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Option Exercise | A | 95.80 | 6,758 | 647,383 | 6,758 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 0.00 | 564 | 0 | 3,617 | 3.1 K to 3.6 K (+18.47 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | A | 95.80 | 57,606 | 5,518,367 | 57,606 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 0.00 | 4,802 | 0 | 44,238 | 39.4 K to 44.2 K (+12.18 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Option Exercise | A | 95.80 | 37,565 | 3,598,539 | 37,565 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 0.00 | 3,132 | 0 | 20,537 | 17.4 K to 20.5 K (+17.99 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 95.80 | 37,565 | 3,598,539 | 37,565 |